X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (593) 593
Newspaper Article (85) 85
Newsletter (82) 82
Book Chapter (77) 77
Conference Proceeding (3) 3
Magazine Article (3) 3
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
brentuximab vedotin (770) 770
science & technology (380) 380
life sciences & biomedicine (374) 374
humans (290) 290
lymphomas (226) 226
oncology (215) 215
hodgkin lymphoma (181) 181
hematology (173) 173
cancer (164) 164
immunoconjugates - therapeutic use (140) 140
chemotherapy (128) 128
care and treatment (122) 122
hodgkin disease - drug therapy (120) 120
male (118) 118
female (106) 106
adult (97) 97
research (96) 96
non-hodgkin's lymphomas (92) 92
stem cells (92) 92
middle aged (89) 89
antineoplastic agents - therapeutic use (85) 85
transplantation (82) 82
cd30 (80) 80
drug therapy (78) 78
treatment outcome (78) 78
hodgkin's disease (76) 76
lymphoma (75) 75
clinical trials (73) 73
immunotherapy (73) 73
biotechnology industry (71) 71
t cells (66) 66
aged (63) 63
relapse (61) 61
hemic and lymphatic diseases (59) 59
immunoconjugates - adverse effects (59) 59
young adult (58) 58
antibodies (56) 56
biological products industry (55) 55
patients (54) 54
anaplastic large cell lymphoma (53) 53
biological products (52) 52
monoclonal antibodies (52) 52
antineoplastic combined chemotherapy protocols - therapeutic use (50) 50
hodgkin disease - therapy (49) 49
medical research (49) 49
pharmacology & pharmacy (49) 49
hodgkin disease - pathology (48) 48
stem cell transplantation (48) 48
tumors (48) 48
immunoconjugates - administration & dosage (47) 47
recurrence (47) 47
adolescent (45) 45
lymphoma, large-cell, anaplastic - drug therapy (44) 44
medicine & public health (44) 44
pharmaceutical industry (44) 44
cd30 antigen (43) 43
viral antibodies (42) 42
metastasis (40) 40
product development (40) 40
analysis (38) 38
antibody-drug conjugate (38) 38
biopharmaceutics (38) 38
dosage and administration (38) 38
nivolumab (38) 38
diseases (37) 37
prognosis (37) 37
brentuximab (36) 36
clinical trials as topic (36) 36
animals (34) 34
drug approval (34) 34
health aspects (34) 34
immune system diseases (34) 34
ki-1 antigen - metabolism (34) 34
medicine, experimental (34) 34
hematopoietic stem cells (33) 33
hodgkin disease - mortality (33) 33
hodgkin's lymphoma (33) 33
retrospective studies (31) 31
hematology, oncology and palliative medicine (30) 30
mycosis fungoides (30) 30
salvage therapy (30) 30
anaplastic large-cell lymphoma (29) 29
cancer therapies (29) 29
disease-free survival (29) 29
review (29) 29
antineoplastic agents - adverse effects (28) 28
hematopoietic stem cell transplantation (28) 28
pembrolizumab (28) 28
antibodies, monoclonal - therapeutic use (27) 27
autologous stem cell transplantation (27) 27
dermatology (27) 27
fda approval (27) 27
immunology (27) 27
molecular targeted therapy (26) 26
antineoplastic agents, immunological - therapeutic use (25) 25
autografts (25) 25
bendamustine (25) 25
brentuximab vedotin - therapeutic use (25) 25
case report (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (820) 820
Russian (13) 13
German (7) 7
Chinese (5) 5
Czech (3) 3
French (3) 3
Hungarian (3) 3
Polish (3) 3
Italian (2) 2
Japanese (2) 2
Slovenian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 01/2018, Volume 378, Issue 4, pp. 331 - 344
Journal Article
Journal Article
Nature reviews. Drug discovery, ISSN 1474-1784, 01/2012, Volume 11, Issue 1, pp. 19 - 20
Journal Article
by Horwitz, Steven and O'Connor, Owen A and Pro, Barbara and Illidge, Tim and Fanale, Michelle and Advani, Ranjana and Bartlett, Nancy L and Christensen, Jacob Haaber and Morschhauser, Franck and Domingo-Domenech, Eva and Rossi, Giuseppe and Kim, Won Seog and Feldman, Tatyana and Lennard, Anne and Belada, David and Illés, Árpád and Tobinai, Kensei and Tsukasaki, Kunihiro and Yeh, Su-Peng and Shustov, Andrei and Hüttmann, Andreas and Savage, Kerry J and Yuen, Sam and Iyer, Swaminathan and Zinzani, Pier Luigi and Hua, Zhaowei and Little, Meredith and Rao, Shangbang and Woolery, Joseph and Manley, Thomas and Trümper, Lorenz and Aboulafia, David and Alpdogan, Onder and Ando, Kiyoshi and Arcaini, Luca and Baldini, Luca and Bellam, Naresh and Bartlett, Nancy and Yehuda, Dina Ben and Benedetti, Fabio and Borchman, Peter and Bordessoule, Dominique and Brice, Pauline and Briones, Javier and Caballero, Dolores and Carella, Angelo Michele and Chang, Hung and Cheong, June Weon and Cho, Seok-Goo and Choi, Ilseung and Choquet, Sylvain and Colita, Andrei and Congui, Angela Giovanna and D'amore, Francesco and Dang, Nam and Davison, Kelly and de Guibert, Sophie and Brown, Peter de Nully and Delwail, Vincent and Demeter, Judit and di Raimondo, Francesco and Do, Young Rok and Domingo, Eva and Douvas, Michael and Dreyling, Martin and Ernst, Thomas and Fay, Keith and Ferrero, Silvia Fernandez and Flinn, Ian Winchester and Forero-Torres, Andres and Fox, Christopher and Friedberg, Jonathan and Fukuhara, Noriko and Garcia-Marco, Jose and Cruz, Jorge Gayoso and Codina, Jose Gomez and Gressin, Remy and Grigg, Andrew and Gurion, Ronit and Haioun, Corinne and Hajek, Roman and Hanel, Mathias and Hatake, Kiyohiko and Hensen, Robert and Horowitz, Netanel and Huttmann, Andreas and Illes, Arpad and Ishizawa, Kenichi and Islas-Ohlmayer, Miguel and Jacobsen, Eric and Janakiram, Murali and Jurczak, Wojciech and Kaminski, Mark and Kato, Koji and Kirgner, Ilya and Kuo, Ching-Yuan and Lazaroiu, Mihaela Cornelia and Du, Katell Le and Lee, Jong-Seok and LeGouill, Steven and ... and ECHELON-2 Study Group and ECHELON 2 Study Grp
The Lancet (British edition), ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 229 - 240
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 2/2016, Volume 113, Issue 6, pp. 1624 - 1629
.... Recently, anti-PD1 immunotherapy or treatment with the anti-CD30 toxin conjugate brentuximab vedotin (BV... 
Ruxolitinib | Brentuximab vedotin | Navitoclax | Hodgkin's lymphoma | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Caspase 7 - metabolism | Pyrazoles - therapeutic use | Apoptosis - drug effects | Hodgkin Disease - pathology | Humans | Caspase 3 - metabolism | STAT Transcription Factors - metabolism | Hodgkin Disease - enzymology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Immunoconjugates - pharmacology | Hodgkin Disease - drug therapy | Immunoconjugates - therapeutic use | Phosphorylation - drug effects | Drug Evaluation, Preclinical | Disease Models, Animal | Pyrazoles - pharmacology | Aniline Compounds - pharmacology | Janus Kinase 2 - genetics | Treatment Outcome | Gene Dosage | Mitochondria - metabolism | Mitochondria - drug effects | Enzyme Activation - drug effects | Sulfonamides - pharmacology | Blotting, Western | Disease Progression | Animals | Signal Transduction - drug effects | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Aniline Compounds - therapeutic use | bcl-X Protein - metabolism | Dosage and administration | Observations | Drug therapy | Drug interactions | Hodgkin's disease | Prescription drugs | Phosphorylation | Lymphomas | Cytokines | Gene expression | Rodents | Index Medicus | Biological Sciences | ruxolitinib | brentuximab vedotin
Journal Article